• iTeos Therapeutics' (ITOS) "Outperform" Rating Reaffirmed at Wedbush

    Source: Buzz FX / 10 Jan 2025 20:41:14   America/New_York


    iTeos Therapeutics' (ITOS) "Outperform" Rating Reaffirmed at Wedbush Written by MarketBeat January 10, 2025 Share Link copied to clipboard. iTeos Therapeutics ( NASDAQ:ITOS - Get Free Report ) 's stock had its "outperform" rating reiterated
    Read more...
Share on,